Cambridge Investment Research Advisors’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$144K Buy
96,469
+729
+0.8% +$1.11K ﹤0.01% 3744
2025
Q4
$126K Sell
95,740
-41,285
-30% -$51.8K ﹤0.01% 3671
2025
Q3
$188K Sell
137,025
-32,000
-19% -$42.6K ﹤0.01% 3499
2025
Q2
$238K Buy
169,025
+5,035
+3% +$7.14K ﹤0.01% 3175
2025
Q1
$261K Sell
163,990
-12,500
-7% -$30.4K ﹤0.01% 2989
2024
Q4
$625K Buy
176,490
+14,050
+9% +$56.1K ﹤0.01% 2245
2024
Q3
$737K Sell
162,440
-26,785
-14% -$122K ﹤0.01% 2096
2024
Q2
$802K Sell
189,225
-3,950
-2% -$15.4K ﹤0.01% 1928
2024
Q1
$637K Sell
193,175
-32,198
-14% -$72.1K ﹤0.01% 2057
2023
Q4
$476K Sell
225,373
-36,122
-14% -$70.2K ﹤0.01% 2215
2023
Q3
$554K Sell
261,495
-47,120
-15% -$128K ﹤0.01% 2006
2023
Q2
$991K Buy
308,615
+101,500
+49% +$289K ﹤0.01% 1620
2023
Q1
$449K Sell
207,115
-34,366
-14% -$97.6K ﹤0.01% 2168
2022
Q4
$584K Sell
241,481
-30,360
-11% -$68K ﹤0.01% 1901
2022
Q3
$636K Buy
271,841
+48,000
+21% +$107K ﹤0.01% 1776
2022
Q2
$347K Sell
223,841
-35,000
-14% -$49.5K ﹤0.01% 2248
2022
Q1
$352K Sell
258,841
-17,950
-6% -$20K ﹤0.01% 2411
2021
Q4
$338K Sell
276,791
-7,680
-3% -$11K ﹤0.01% 2423
2021
Q3
$390K Sell
284,471
-2,150
-0.8% -$2.87K ﹤0.01% 2240
2021
Q2
$404K Sell
286,621
-6,000
-2% -$8.73K ﹤0.01% 2225
2021
Q1
$462K Sell
292,621
-34,685
-11% -$61.9K ﹤0.01% 1953
2020
Q4
$520K Sell
327,306
-36,004
-10% -$65.6K ﹤0.01% 1746
2020
Q3
$632K Buy
363,310
+3,058
+0.8% +$5.66K ﹤0.01% 1450
2020
Q2
$785K Buy
360,252
+88,960
+33% +$133K 0.01% 1275
2020
Q1
$323K Buy
271,292
+22,000
+9% +$26.9K ﹤0.01% 1632
2019
Q4
$339K Buy
249,292
+230,247
+1,209% +$333K ﹤0.01% 1834
2019
Q3
$25K Hold
19,045
﹤0.01% 2317
2019
Q2
$27K Hold
19,045
﹤0.01% 2174
2019
Q1
$32K Sell
19,045
-600
-3% -$820 ﹤0.01% 2242
2018
Q4
$20K Sell
19,645
-5,974
-23% -$9.07K ﹤0.01% 2123
2018
Q3
$45K Buy
25,619
+15,084
+143% +$65.8K ﹤0.01% 2197
2018
Q2
$36K Buy
+10,535
New +$40.2K ﹤0.01% 2175
2016
Q4
Sell
-10,025
Closed -$23K 1764
2016
Q3
$23K Sell
10,025
-11,530
-53% -$29.9K ﹤0.01% 1721
2016
Q2
$58K Buy
21,555
+850
+4% +$2.47K ﹤0.01% 1515
2016
Q1
$60K Sell
20,705
-30,970
-60% -$92.7K ﹤0.01% 1548
2015
Q4
$250K Buy
+51,675
New +$208K 0.01% 1219
2014
Q4
Sell
-11,985
Closed -$24K 1421
2014
Q3
$24K Buy
11,985
+1,209
+11% +$2.98K ﹤0.01% 1443
2014
Q2
$33K Hold
10,776
﹤0.01% 1319
2014
Q1
$21K Buy
+10,776
New +$43K ﹤0.01% 1283

Other funds holding GERN

Cambridge Investment Research Advisors's GERN Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Geron (GERN) stake by 0.76% in Q1 2026, buying an estimated $1.11K and bringing the position to 96,469 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.

Cambridge Investment Research Advisors first reported a position in GERN in Q1 2014 and has held it in 39 quarters since. The position peaked at $991K in Q2 2023. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.

  • Cambridge Investment Research Advisors held 96,469 shares of Geron worth $144K as of Q1 2026.
  • Cambridge Investment Research Advisors bought 729 Geron shares in Q1 2026, an estimated $1.11K.
  • Geron made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3744 holding.
  • Cambridge Investment Research Advisors first reported a position in Geron in Q1 2014 and has held it in 39 quarters since.
  • Cambridge Investment Research Advisors's Geron position peaked at $991K in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.